BRPI0606122A2 - tadalafil particulado sólido que tem uma distribuição de tamanho de partìcula bimodal - Google Patents

tadalafil particulado sólido que tem uma distribuição de tamanho de partìcula bimodal

Info

Publication number
BRPI0606122A2
BRPI0606122A2 BRPI0606122-2A BRPI0606122A BRPI0606122A2 BR PI0606122 A2 BRPI0606122 A2 BR PI0606122A2 BR PI0606122 A BRPI0606122 A BR PI0606122A BR PI0606122 A2 BRPI0606122 A2 BR PI0606122A2
Authority
BR
Brazil
Prior art keywords
particle size
size distribution
solid particulate
bimodal particle
particulate tadalafil
Prior art date
Application number
BRPI0606122-2A
Other languages
English (en)
Inventor
Judith Aronhime
Guy Samburski
Yhoshoa Ovadya
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of BRPI0606122A2 publication Critical patent/BRPI0606122A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Secondary Cells (AREA)

Abstract

TADALAFIL PARTICULADO SóLIDO QUE TEM UMA DISTRIBUIçãO DE TAMANHO DE PARTìCULA BIMODAL é fornecido um tadalafil particulado sólido que tem uma distribuição de tamanho de partícula bimodal.
BRPI0606122-2A 2005-08-29 2006-08-29 tadalafil particulado sólido que tem uma distribuição de tamanho de partìcula bimodal BRPI0606122A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71258905P 2005-08-29 2005-08-29
PCT/US2006/033541 WO2007027612A2 (en) 2005-08-29 2006-08-29 Solid particulate tadalafil having a bimodal particle size distribution

Publications (1)

Publication Number Publication Date
BRPI0606122A2 true BRPI0606122A2 (pt) 2009-06-02

Family

ID=37809413

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606122-2A BRPI0606122A2 (pt) 2005-08-29 2006-08-29 tadalafil particulado sólido que tem uma distribuição de tamanho de partìcula bimodal

Country Status (13)

Country Link
US (1) US20070098804A1 (pt)
EP (1) EP1843770B1 (pt)
JP (1) JP2008518041A (pt)
KR (1) KR20070067173A (pt)
AT (1) ATE398451T1 (pt)
BR (1) BRPI0606122A2 (pt)
CA (1) CA2610668A1 (pt)
DE (1) DE602006001510D1 (pt)
ES (1) ES2308750T3 (pt)
IL (1) IL185938A0 (pt)
PL (1) PL1843770T3 (pt)
PT (1) PT1843770E (pt)
WO (1) WO2007027612A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
US7278982B2 (en) 2003-03-27 2007-10-09 Bioactis Limited Powder medicine applicator for nasal cavity
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
GB0712316D0 (en) * 2007-06-26 2007-08-01 Entripneur Ltd A novel powder and its method of manufacture
EP2238979A1 (en) 2009-04-06 2010-10-13 LEK Pharmaceuticals d.d. Active pharmaceutical ingredient adsorbed on solid support
JP2012526726A (ja) * 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
GB2472327B (en) * 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
WO2011030351A2 (en) 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions
WO2013109223A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Particulate formulations of tadalafil in effervescent form
WO2013109230A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising tadalafil
US20160136282A1 (en) 2014-11-18 2016-05-19 Genovate Biotechnology Co., Ltd. Novel formulation of cilostazol, a quinolinone-derivative used for alleviating the symptom of intermittent claudication in patients with peripheral vascular disease
MX2016002581A (es) * 2016-02-26 2017-08-25 Apotex Tech Inc Formulaciones farmaceuticas novedosas que comprenden un inhibidor de pde5.
CA3018191C (en) * 2016-03-31 2022-01-25 ImMutriX Therapeutics, Inc. Method for extracorporeal treatment of preeclampsia and related disorders
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
US6821975B1 (en) * 1999-08-03 2004-11-23 Lilly Icos Llc Beta-carboline drug products
US6465465B1 (en) * 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
CA2420597C (en) * 2000-08-31 2011-05-17 Rtp Pharma Inc. Milled particles
WO2002094219A2 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of erectile dysfunction drugs through an inhalation route
EP1522539B1 (en) * 2001-07-31 2007-01-24 H. Lundbeck A/S Crystalline composition containing escitalopram
US20050042177A1 (en) * 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base

Also Published As

Publication number Publication date
JP2008518041A (ja) 2008-05-29
DE602006001510D1 (de) 2008-07-31
ATE398451T1 (de) 2008-07-15
EP1843770A2 (en) 2007-10-17
ES2308750T3 (es) 2008-12-01
IL185938A0 (en) 2008-08-07
US20070098804A1 (en) 2007-05-03
CA2610668A1 (en) 2007-03-08
KR20070067173A (ko) 2007-06-27
PT1843770E (pt) 2008-08-05
WO2007027612A3 (en) 2007-08-02
WO2007027612A2 (en) 2007-03-08
EP1843770B1 (en) 2008-06-18
PL1843770T3 (pl) 2008-10-31

Similar Documents

Publication Publication Date Title
BRPI0606122A2 (pt) tadalafil particulado sólido que tem uma distribuição de tamanho de partìcula bimodal
AU315691S (en) 'Workbench' board
EP2082390A4 (en) COVER PLATE FOR A LIGHTING DEVICE AND LIGHTING DEVICE THEREFOR
HK1080125A1 (en) Molding for drywall ceiling grid
UY3722Q (es) Estufa
AU311249S (en) A lamp
EP2042526A4 (en) DEODORIZING PARTICLE
EP1958489A4 (en) PARTICLE ACCOMMODATION AND METHOD THEREFOR
IL187051A0 (en) Competitive particle immunoassay methods utilizing fluorescent
NL1031392A1 (nl) Granulair vast wasdeeltje.
GB0504713D0 (en) The air accelerator
EP2005968A4 (en) NANOCOMPOSITE PARTICLE
AU310105S (en) Plate
CA122495S (en) Ceiling occupancy sensor
EP1961093A4 (en) CEILING BOX
DE602006008339D1 (en) Zolpidemtabletten
ES1063656Y (es) Cajita colgante con ambientador incorporado
CA113787S (en) Lever
IN2014CN04215A (pt)
HK1121518A1 (en) Lampshade for receiving an illuminant
GB0519148D0 (en) Improved particle metrology
AU310162S (en) Housing for lighting apparatus
CA113788S (en) Lever
CA113786S (en) Lever
AU311808S (en) Brake calliper

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.